Tag: clinical
Biophytis: The United States authorizes Biophytis to launch a final phase of clinical trials in sarcopenia
(BFM Bourse) – The biopharmaceutical company has obtained the green light from the FDA to launch its phase III study SARA-31 for its potential treatment against sarcopenia. Biophytis obtained similar…
Clinical diagnosis: Novacyt finalizes the acquisition of the British Yourgene – 09/08/2023 at 3:25 p.m.
(AOF) – Novacyt announces the finalization of the acquisition by its British subsidiary Novacyt UK of the entire share capital of Yourgene Health plc, an international molecular diagnostics group. The…
Clinical diagnosis: Novacyt finalizes the acquisition of the British Yourgene
(AOF) – Novacyt announces the finalization of the acquisition by its British subsidiary Novacyt UK of the entire share capital of Yourgene Health plc, an international molecular diagnostics group. The…
MedinCell – Successful recruitment for the phase 3 clinical study of F14 (mdc-CWM), a first-in-class localized treatment to relieve pain after knee replacement surgery – 08/30/2023 at 18 :54
MedinCell Announces Successful Recruitment for Phase 3 Clinical Study of F14 (mdc-CWM), a First-in-Class Localized Treatment for Post-Knee Replacement Pain Relief – Recruitment is complete after randomization of 151 patients…
Genfit: publication of new data on the clinical performance of NIS2+
(AOF) – Genfit, a late-stage biopharmaceutical company committed to improving the lives of patients with rare and serious liver diseases, announces the publication of new data on the clinical performance…
Sensorion submits UK clinical trial authorization application for OTOF-GT, its most advanced gene therapy product
By Claude Leguilloux Published on 07/10/2023 at 07:46 (Boursier.com) — Sensorion a pioneering clinical-stage biotechnology company dedicated…
Sensorion submits UK clinical trial authorization application for OTOF-GT – 2023-07-10 08:38
(AOF) – Sensorion, a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies to restore, treat and prevent hearing loss, announces that it has submitted an initial Clinical Trial Authorization…
Sensorion submits UK clinical trial authorization application for OTOF-GT, its most advanced gene therapy product – 7/10/2023 at 07:30
Sensorion submits an application for clinical trial authorization, in the UK, for OTOF-GT, its most advanced gene therapy product. Montpellier, July 10, 2023 at 7:30 a.m. CET – Sensorion (FR0012596468…
Aelis Farma: positive opinion from the DSMB for the continuation of the phase 2b clinical study with AEF0117 in cannabis addiction – 07/05/2023 at 07:00
Aelis Farma receives the positive opinion of the DSMB for the continuation without change to the protocol of its phase 2b clinical study with AEF0117 in cannabis addiction The excellent…
Sensorion publishes positive efficacy data in the SENS-401 phase 2a clinical study – 07/05/2023 at 07:30
Positive preliminary data shows that SENS-401 has a clinically significant effecton preservation of residual hearing after cochlear implantation in all patientsadults treated so far.• On June 19, Sensorion announced the…
AstraZeneca: a clinical study struggles to convince
(CercleFinance.com) – The title AstraZeneca shows a heavy decline on Monday on the London Stock Exchange following the presentation by the pharmaceutical group of results considered mixed in lung cancer.…
AstraZeneca: A clinical study struggles to convince
(CercleFinance.com) – The title AstraZeneca shows a heavy decline on Monday on the London Stock Exchange following the presentation by the pharmaceutical group of results considered mixed in lung cancer.…